Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Reduced Intensity Double Umbilical Cord Blood Transplantation Using Fludarabine, Melphalan, and Low Dose Total Body Radiation

NCT01408563 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01408563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01408563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Reduced Intensity Double Umbilical Cord Blood Transplantation Using Fludarabine, Melphalan, and Low Dose Total Body Radiation
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2011
Completion date
June 30, 2017
Enrollment
33 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute myelogenous leukemia, chronic lymphocytic leukemia, hodgkin's lymphoma, multiple myeloma, non-hodgkin's lymphoma